B-Celera

B-celera has innovated a technology that provides a novel route of aspirin administration through direct systemic absorption on the inner cheek (buccal administration) in two forms (rapid or slow-release). Compared to the traditional oral route, our buccal administration has a therapeutic edge both in emergency and chronic use.